BofA/Merrill Lynch Downgrades Hospira (HSP) to Neutral

February 13, 2013 12:33 PM EST Send to a Friend
Get Alerts HSP Hot Sheet
Price: $43.64 -0.27%

Rating Summary:
    5 Buy, 12 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 10 | New: 7
Trade HSP Now!
Join SI Premium – FREE
Intra-day, BofA/Merrill Lynch downgraded Hospira (NYSE: HSP) from Buy to Neutral following Q4 results.

For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.

Shares of Hospira closed at $34.95 yesterday.




You May Also Be Interested In


Related Categories

Analyst EPS View, Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment